132 related articles for article (PubMed ID: 7301655)
21. [Bone scintigraphy, plasma ALP, TAP and PAP in patients with prostatic cancer].
Imamura A; Hoshi H; Jinnouchi S; Samejima M; Watanabe K
Kaku Igaku; 1988 Feb; 25(2):177-81. PubMed ID: 3386031
[No Abstract] [Full Text] [Related]
22. Reference intervals for two bone-derived enzyme activities in serum: bone isoenzyme of alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TR-ACP).
Panteghini M; Pagani F
Clin Chem; 1989 Jan; 35(1):180-1. PubMed ID: 2910567
[No Abstract] [Full Text] [Related]
23. Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
Merrick MV; Ding CL; Chisholm GD; Elton RA
Br J Urol; 1985 Dec; 57(6):715-20. PubMed ID: 4084732
[TBL] [Abstract][Full Text] [Related]
24. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
[TBL] [Abstract][Full Text] [Related]
25. Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis.
Akimoto S; Furuya Y; Akakura K; Ito H
Endocr J; 1998 Feb; 45(1):97-104. PubMed ID: 9625452
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.
Lorente JA; Morote J; Raventos C; Encabo G; Valenzuela H
J Urol; 1996 Apr; 155(4):1348-51. PubMed ID: 8632571
[TBL] [Abstract][Full Text] [Related]
27. Bone alkaline phosphatase and prostate-specific antigen in the monitoring of prostate cancer.
Cooper EH; Whelan P; Purves D
Prostate; 1994 Nov; 25(5):236-42. PubMed ID: 7526352
[TBL] [Abstract][Full Text] [Related]
28. Behavior of bone alkaline phosphatase (BAP) determined with immunoradiometric assay in metastatic prostate cancer.
Lorente JA; Morote J
Int J Biol Markers; 1994; 9(3):145. PubMed ID: 7530275
[No Abstract] [Full Text] [Related]
29. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
Morote J; Lorente JA; Encabo G
Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
[TBL] [Abstract][Full Text] [Related]
30. Bone imaging and serum phosphatases in prostatic carcinoma.
Bishop MC; Hardy JG; Taylor MC; Wastie ML; Lemberger RJ
Br J Urol; 1985 Jun; 57(3):317-24. PubMed ID: 4005501
[TBL] [Abstract][Full Text] [Related]
31. New assays for prostatic acid phosphatase and alkaline phosphatase isoenzymes.
Pontes JE
Urology; 1981 Mar; 17(Suppl 3):38-9. PubMed ID: 7010753
[No Abstract] [Full Text] [Related]
32. Scintigraphic changes in bone metastasis from prostate cancer after hormonal therapy--comparison with tumor markers and bone X-ray.
Koizumi K; Uchiyama G; Komatsu H
Ann Nucl Med; 1994 Nov; 8(4):225-30. PubMed ID: 7535550
[TBL] [Abstract][Full Text] [Related]
33. [Correlation and development of the enzyme activity of phosphatases and the gammagraphic distribution of bone deposits in prostatic cancer (preliminary study)].
Maganto Pavón E; Mateos Torres JA; Verdú Tartajo F; Boronat Tormo F; Mayayo Dehesa T; Romero Aguirre C
Actas Urol Esp; 1981; 5(2):93-8. PubMed ID: 7270286
[No Abstract] [Full Text] [Related]
34. Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase.
Burlina A; Rubin D; Secchiero S; Sciacovelli L; Zaninotto M; Plebani M
Clin Chim Acta; 1994 May; 226(2):151-8. PubMed ID: 7923810
[TBL] [Abstract][Full Text] [Related]
35. The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients.
Body JJ; Dumon JC; Blocklet D; Darte C
Eur J Cancer; 1997 Sep; 33(10):1578-82. PubMed ID: 9389918
[TBL] [Abstract][Full Text] [Related]
36. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT
J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786
[TBL] [Abstract][Full Text] [Related]
37. A variant alkaline phosphatase found in a case of gastric carcinoma with super bone scan.
Kobayashi F; Ikeda T; Tozuka S; Noguchi O; Fukuma T; Sakamoto S; Marumo F; Komoda T; Sakagishi Y; Sato C
Gut; 1995 Feb; 36(2):299-302. PubMed ID: 7883233
[TBL] [Abstract][Full Text] [Related]
38. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
Hetherington JW; Siddall JK; Cooper EH
Eur Urol; 1988; 14(1):1-5. PubMed ID: 2449352
[TBL] [Abstract][Full Text] [Related]
39. An unusual alkaline phosphatase isoenzyme in a patient with concomitant marked elevation of acid phosphatase without clinical evidence of prostatic carcinoma.
Lee LM
Clin Chim Acta; 1976 Sep; 71(2):221-7. PubMed ID: 61077
[TBL] [Abstract][Full Text] [Related]
40. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
Lorente JA; Valenzuela H; Morote J; Gelabert A
Eur J Nucl Med; 1999 Jun; 26(6):625-32. PubMed ID: 10369948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
